Table 1 Characteristics of enrolled patients
Characteristic | No of patients (n = 169) (%) |
|---|---|
Department | |
- Day Hospital | 77 (45.6) |
- Pediatric Surgery | 36 (21.3) |
- Pediatrics | 24 (14.2) |
- Gastroenterology | 14 (8.3) |
- Blood Drawing Center | 12 (7.1) |
- Emergency Department | 6 (3.5) |
Age | |
- Mean ± SD | 10.5 ± 4.1 |
- ≤ 5 | 28 (16.6) |
- 6–11 | 61 (36.1) |
- 12–17 | 80 (47.3) |
Sex | |
- M | 85 (50.3) |
- F | 84 (49.7) |
Citizenship | |
- Italy | 154 (91) |
- Romania | 4 (2.4) |
- Serbia | 4 (2.4) |
- Albania | 2 (1.2) |
- China | 1 (0.6) |
- Pakistan | 1 (0.6) |
- Spain | 1 (0.6) |
- Turkey | 1 (0.6) |
- UK | 1 (0.6) |
Comorbidities | 94 (55.6) |
- Malformation/Syndrome/Cerebral Palsy | 22 (23.4) |
- Obesity | 12 (12.8) |
- Prematurity | 10 (10.6) |
- Respiratory | 10 (10.6) |
- Cardiac | 5 (5.3) |
- Diabetes | 4 (4.3) |
- Other | 31 (33) |
Cohabitant healthcare worker | 23 (13.6) |
Having an infected cohabitant | 20 (11.8) |
- 1 month before | 7 |
- 2 months before | 5 |
- 3 months before | 5 |
- More than 3 months before | 1 |
- Unspecified | 2 |
- Tested by nasopharyngeal swab | 20 (100) |
- Positive | 4 (20) |
Nasopharyngeal swab | |
- Tested | 122 (72.2) |
- Positive | 5 (4.1) |
○ 1 month before | 2 |
○ 2 months before | 2 |
○ 3 months before | 1 |
○ More than 3 months before | 0 |
Anti-SARS-CoV-2 Spike Protein IgG Antibodies | |
- Positive | 16 (9.5) |
- Negative | 153 (90.5) |